Medical 21 Secures Up To $20 Million Commitment For Its Pioneering Cardiac Bypass Technology
Amount Raised
$20 Million
Round Type
Funding Round
PlymouthManufacturingBiotechnologyDescription
Medical 21, a medtech company aiming to transform heart bypass surgery with a revolutionary artificial graft, says it has successfully closed a $20 million commitment pursuant to Regulation D, Rule 506(c) under the Securities Act of 1933, as amended, to implement its business plan.
Who to call at Medical 21, and when
A new round usually means Medical 21 is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Medical 21 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Medical 21, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Medical 21. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medical 21 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Medical 21 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.